The Board has considered and approved the appointment of Mrs. Padmaja Kalyani Sadhanala as an Additional director, Non Executive and Non Independent Director and Mr. Revoor Ramachandra as an Additional director, Non Executive Independent Director of the Company.
Venmax Drugs & Pharmaceuticals Ltd. Press Release Mar 30 2026
Filed with BSE · · 3 pages · English
Release
Venmax Drugs & Pharmaceuticals Ltd. on 6ix
Earlier from Venmax Drugs & Pharmaceuticals
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Mar 27 2026
- Board Meeting Outcome for Modification Of Draft Scheme Of Amalgamation
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Mar 26 2026
- Closure of Trading Window
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Mar 23 2026
Later from Venmax Drugs & Pharmaceuticals
- Regulation 31(4) - SAST Disclosure
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Apr 06 2026
- Board Meeting Intimation for Audited Standalone Financial Results Of The Company For The Quarter And Year Ended March 31, 2026.
- Venmax Drugs & Pharmaceuticals Ltd. Press Release May 06 2026
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Jun 27 2026
Follow Venmax Drugs & Pharmaceuticals into a list and get an email when it puts out news.
Follow Venmax Drugs & Pharmaceuticals